Plus Therapeutics (PSTV) Operating Leases (2019 - 2025)
Plus Therapeutics (PSTV) reported Operating Leases of $15000.0 for Q4 2025, down 51.61% year-over-year from $31000.0 in Q4 2024, and down 51.61% quarter-over-quarter from $31000.0 in Q4 2024.
Plus Therapeutics (PSTV) Operating Leases (2019 - 2025) Analysis & Trends
Plus Therapeutics (PSTV) has 7 years of Operating Leases data on file, last reported at $15000.0 in Q4 2025.
- Operating Leases for Q4 2025 came in at $15000.0, down 51.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $15000.0 (down 51.61% YoY), and the FY2025 annual result was $15000.0, down 51.61% from the prior year.
- Operating Leases declined to $15000.0 in Q4 2025 per PSTV's latest filing, from $31000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $530000.0 in Q2 2021 and troughed at $15000.0 in Q4 2025.
- A 5-year average of $186470.6 and a median of $136000.0 in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2021 and 2024: Operating Leases decreased 7.52% in 2021, then slumped 66.1% in 2024.
- A 5-year view of Operating Leases shows it stood at $269000.0 in 2021, then sank by 47.58% to $141000.0 in 2022, then sank by 39.72% to $85000.0 in 2023, then plunged by 63.53% to $31000.0 in 2024, then sank by 51.61% to $15000.0 in 2025.
- Business Quant data shows PSTV's Operating Leases at $15000.0 in Q4 2025, $31000.0 in Q4 2024, and $40000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 85,000.00 |
| Sep 30, 2023 | 118,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Sep 30, 2022 | 172,000.00 |
| Jun 30, 2022 | 202,000.00 |
| Mar 31, 2022 | 235,000.00 |
| Dec 31, 2021 | 269,000.00 |
| Sep 30, 2021 | 504,000.00 |
| Jun 30, 2021 | 530,000.00 |
| Mar 31, 2021 | 503,000.00 |
| Dec 31, 2020 | 528,000.00 |
| Sep 30, 2020 | 545,000.00 |
| Jun 30, 2020 | 589,000.00 |